LRH-1/NR5a2 in regulation of the immune system

Lade...
Vorschaubild
Dateien
Schwaderer_0-425282.pdf
Schwaderer_0-425282.pdfGröße: 11.24 MBDownloads: 587
Datum
2017
Herausgeber:innen
Kontakt
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
DOI (zitierfähiger Link)
ArXiv-ID
Internationale Patentnummer
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Open Access Green
Sammlungen
Core Facility der Universität Konstanz
Gesperrt bis
Titel in einer weiteren Sprache
Forschungsvorhaben
Organisationseinheiten
Zeitschriftenheft
Publikationstyp
Dissertation
Publikationsstatus
Published
Erschienen in
Zusammenfassung

The orphan nuclear receptor Liver receptor homolog-1 (LRH-1/NR5a2) is involved in the regulation of development, lipid metabolism and proliferation, and is predominantly expressed in epithelial tissues. However, its expression in immune cells and its function in immune regulation is currently poorly understood. Here, LRH-1 expression in primary and secondary lymphatic tissues, as well as in mature CD4+ and CD8+ T cells, was examined. Based on in silico analysis, potential LRH-1 binding sites within the promoter of CD95/Fas ligand (FasL), an apoptosis-inducing ligand and regulator of immune cell homeostasis and cytotoxicity, were identified. LRH-1 directly binds to its binding sites in the FASLG promoter and thereby drives FASLG transcription. Furthermore, mutations in the LRH-1 binding sites reduce FASLG promoter activity. Pharmacological inhibition of LRH-1 decreased activation-induced FasL mRNA expression, as well as FasL-mediated activation-induced T cell apoptosis and cytotoxicity. Moreover, in a mouse model of Concanavalin A-induced and FasL-mediated hepatitis, pharmacological inhibition of LRH-1 resulted in decreased hepatic FasL expression and a significant reduction of associated liver damage. Also in cells of the innate immune system, i.e. macrophages, pharmacological LRH-1 inhibition illustrated a regulatory function on the toll-like receptor-induced expression of pro-inflammatory cytokines, such as TNFα, IL-6, and IL-1 and the respiratory capacity. In summary, these data describe different regulatory roles of LRH-1 in T cells and macrophages, and reveal important insights into the potential of pharmacological intervention of LRH-1 in immunopathologies.

Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
570 Biowissenschaften, Biologie
Schlagwörter
Konferenz
Rezension
undefined / . - undefined, undefined
Zitieren
ISO 690SCHWADERER, Juliane, 2017. LRH-1/NR5a2 in regulation of the immune system [Dissertation]. Konstanz: University of Konstanz
BibTex
@phdthesis{Schwaderer2017LRH1N-40165,
  year={2017},
  title={LRH-1/NR5a2 in regulation of the immune system},
  author={Schwaderer, Juliane},
  address={Konstanz},
  school={Universität Konstanz}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/40165">
    <dcterms:abstract xml:lang="eng">The orphan nuclear receptor Liver receptor homolog-1 (LRH-1/NR5a2) is involved in the regulation of development, lipid metabolism and proliferation, and is predominantly expressed in epithelial tissues. However, its expression in immune cells and its function in immune regulation is currently poorly understood. Here, LRH-1 expression in primary and secondary lymphatic tissues, as well as in mature CD4+ and CD8+ T cells, was examined. Based on in silico analysis, potential LRH-1 binding sites within the promoter of CD95/Fas ligand (FasL), an apoptosis-inducing ligand and regulator of immune cell homeostasis and cytotoxicity, were identified. LRH-1 directly binds to its binding sites in the FASLG promoter and thereby drives FASLG transcription. Furthermore, mutations in the LRH-1 binding sites reduce FASLG promoter activity. Pharmacological inhibition of LRH-1 decreased activation-induced FasL mRNA expression, as well as FasL-mediated activation-induced T cell apoptosis and cytotoxicity. Moreover, in a mouse model of Concanavalin A-induced and FasL-mediated hepatitis, pharmacological inhibition of LRH-1 resulted in decreased hepatic FasL expression and a significant reduction of associated liver damage. Also in cells of the innate immune system, i.e. macrophages, pharmacological LRH-1 inhibition illustrated a regulatory function on the toll-like receptor-induced expression of pro-inflammatory cytokines, such as TNFα, IL-6, and IL-1 and the respiratory capacity. In summary, these data describe different regulatory roles of LRH-1 in T cells and macrophages, and reveal important insights into the potential of pharmacological intervention of LRH-1 in immunopathologies.</dcterms:abstract>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/40165"/>
    <dc:rights>terms-of-use</dc:rights>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/40165/3/Schwaderer_0-425282.pdf"/>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dcterms:issued>2017</dcterms:issued>
    <dc:creator>Schwaderer, Juliane</dc:creator>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/40165/3/Schwaderer_0-425282.pdf"/>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-09-27T05:51:28Z</dcterms:available>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-09-27T05:51:28Z</dc:date>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dcterms:title>LRH-1/NR5a2 in regulation of the immune system</dcterms:title>
    <dc:language>eng</dc:language>
    <dc:contributor>Schwaderer, Juliane</dc:contributor>
  </rdf:Description>
</rdf:RDF>
Interner Vermerk
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Kontakt
URL der Originalveröffentl.
Prüfdatum der URL
Prüfungsdatum der Dissertation
July 25, 2017
Hochschulschriftenvermerk
Konstanz, Univ., Diss., 2017
Finanzierungsart
Kommentar zur Publikation
Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Nein
Begutachtet
Diese Publikation teilen